Global Life Science Ventures (GLSV) has appointed Dr Bert SJ van Toor as investment manager. As a member of the GLSV investment team, Dr van Toor will operate from the company’s Zug office in Switzerland. He will be actively involved in evaluating potential investments, developing GLSV’s portfolio of companies in the life sciences and providing further counseling for the management of the fund.
Dr van Toor qualified as a medical doctor at the University of Amsterdam in 1988 and obtained accreditation as a clinical pharmacologist in Mainz, Germany. From 1988 to 1991, he was a resident at two university hospitals in The Netherlands. From 1992 to 2001 he held positions of increasing responsibility at Boehringer Ingelheim in Germany, in clinical pharmacology and global clinical research. And from 2001 onwards he worked at Bayer AG in several positions including global project management, clinical development and as interim medical director of the Benelux region. He was also involved in the evaluation of many in- and out-licensing opportunities, reviewing and optimizing R&D processes, as well as providing guidance on diverse research and development projects in respiratory disease and urology.